Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1041 of 1,261

  1. US 7491802

    Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

    Takeda Pharmaceutical Company Limited · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  2. US 7491722

    Pyridazin-3(2H)-one derivatives

    Laboratories Almirall, S.A. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  3. US 7491715

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  4. US 7491736

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  5. US 7491707

    Synthetic lipid-a-analogs and uses thereof

    Biomira, Inc. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  6. US 7491677

    Combinatorial synthesis

    BASF CATALYSTS LLC · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  7. US 7491847

    Methods for isolating propargylated aminoindans

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  8. US 7491730

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  9. US 7488806

    Human antibodies to human delta like ligand 4

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  10. US 7488727

    Thiazole compounds useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  11. US 7488710

    SFRP and peptide motifs that interact with SFRP and methods of their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  12. US 7488758

    Levalbuterol hydrochloride polymorph B

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  13. US 7488750

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  14. US 7488805

    Apoptosis proteins

    Rigel Pharmaceuticals, Inc. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  15. US 7488804

    Modified fusion molecules for treatment of allergic disease

    The Regents of the University of California · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  16. US 7488480

    Use of passive myostatin immunization in egg laying vertebrates

    Regents of the University of Minnesota · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  17. US 7488735

    Quinuclidine amide derivatives

    Laboratories Almirall, S.A. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  18. US 7488808

    Janus family kinases and identification of immune modulators

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  19. US 7485415

    Sequence analysis of the tetravalent rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  20. US 7485724

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  21. US 7485307

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  22. US 7485660

    Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  23. US 7485457

    Isolated/cloned human NT2 cell lines expressing serotonin and GABA

    The United States of America—Department of Veterans Affairs · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  24. US 7485317

    Thermo-reversible polymer for intralumenal implant

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.